Günes, C*., Wezel, F., Southgate, J., Bolenz, C. Implications of TERT promoter mutations and telomerase activity for urothelial carcinogenesis. Nature Reviews Urology. 2018 Mar 29. doi: 10.1038/s41585-018-0001-5. [Epub ahead of print] Review.
* Corresponding author

Bolenz, C., Knauf, D., John, A., Erben, P., Steidler, A., Schneider, S.W. Günes, C., Gorzelanny, C. Decreased Invasion of Urothelial Carcinoma of the Bladder by Inhibition of Matrix-Metalloproteinase 7. Bladder Cancer, vol. 4, no. 1, pp. 67-75, 2018

Bottke D, Bolenz C, Ott S, Cebulla A, Wiegel T. When should the primary tumor of metastatic bladder or prostate cancer be treated using a nonsurgical regimen?. Urologe A. 2017 May;56(5):579-584. doi: 10.1007/s00120-017-0356-x. German. PubMed PMID: 28349190.

Ebert AK. Acute Flank Pain in Children and Adolescents. Aktuelle Urol. 2017 Sep;48(5):452-458. doi: 10.1055/s-0043-103501. Epub 2017 Sep 5. German.

Ebert AK, Stehr M. Phimosis in a 10-yr-old Boy Without Urinary Infection-How to Inform Parents: Against Circumcision. Eur Urol Focus. 2017 Apr;3(2-3):151-152. doi: 10.1016/j.euf.2017.06.006. Epub 2017 Jun 20.

Ebert AK. The German research network CURE-Net : A benefit for patients with rare diseases]. Urologe A. 2017 Jul;56(7):905-909. doi: 10.1007/s00120-017-0403-7. Review. German.

Ebert AK, Lange T, Reutter H, Jenetzky E, Stein R, Boemers TM, Hirsch K, Rösch WH, Zwink N. Evaluation of sexual function in females with exstrophy-epispadias-complex: A survey of the multicenter German CURE-Net. J Pediatr Urol. 2017 Apr;13(2):183.e1-183.e6. doi: 10.1016/j.jpurol.2016.04.052. Epub 2016 Jul 13.

Eckstein et al. A multicenter round robin test of PD-L1 expression assessment in urothelial bladder cancer by immunohistochemistry and RT-qPCR with emphasis on prognosis prediction after radical cystectomy. Oncotarget. 2018 Feb 19;9(19):15001-15014. doi: 10.18632/oncotarget.24531. eCollection 2018 Mar 13

Erben P, Wezel F, Wirtz R, Martini T, Stein D, Weis CA, Hartmann A, Bolenz C. [Role of the human ErbB family receptors in urothelial carcinoma of the bladder: mRNA expression status and prognostic relevance]. Aktuelle Urol. 2017 Aug;48(4):356-362. doi: 10.1055/s-0043-110403. Epub 2017 Jul 27. German.

Gunes C, Avila AI, Rudolph KL. Telomeres in cancer. Differentiation. 2017 Dec 21;99:41-50. doi: 10.1016/j.diff.2017.12.004. [Epub ahead of print] Review. PMID: 29291448

Hausmann D, Aksöz N, von Hardenberg J, Martini T, Westhoff N, Buettner S, Schoenberg SO, Riffel P. Prostate cancer detection among readers with different degree of experience using ultra-high b-value diffusion-weighted Imaging: Is a non-contrast protocol sufficient to detect significant cancer? Eur Radiol. 2018 Feb;28(2):869-876. doi: 10.1007/s00330-017-5004-8. Epub 2017 Aug 10. PMID: 28799090

Hofbauer S, Kalogirou C, Roghmann F, Seitz AK, Vallo S, Wezel F, Worst T, Nawroth R. Modern networks : Topics in the working group "Bladder cancer research" of the GeSRU Academics. Urologe A. 2017 Feb;56(2):202-207. doi: 10.1007/s00120-016-0217-z. Review. German. PubMed PMID: 27604705.

John A, Gorzelanny C, Bauer AT, Schneider SW, Bolenz C. Role of the Coagulation System in Genitourinary Cancers: Review. Clin Genitourin Cancer. 2017 Jul 26. pii: S1558-7673(17)30210-0. doi: 10.1016/j.clgc.2017.07.013. [Epub ahead of print] Review.

Krabbe LM, Heitplatz B, Preuss S, Hutchinson RC, Woldu SL, Singla N, Boegemann M, Wood CG, Karam JA, Weizer AZ, Raman JD, Remzi M, Rioux-Leclercq N, Haitel A, Rapoport LM, Glybochko PV, Roscigno M, Bolenz C, Bensalah K, Sagalowsky AI, Shariat SF, Lotan Y, Xylinas E, Margulis V. Prognostic Value of PD-1 and PD-L1 Expression in Patients with High Grade Upper Tract Urothelial Carcinoma. J Urol. 2017 Dec;198(6):1253-1262. doi: 10.1016/j.juro.2017.06.086. Epub 2017 Jun 28.

Kriegmair MC, Ritter M, Michel MS, Bolenz C. Modern endoscopic imaging tools for urothelial carcinoma of the urinary bladder. Aktuelle Urol. 2017 Aug;48(4):296-305. doi: 10.1055/s-0043-109820. Epub 2017 Jul 27. German.

Kriegmair MC, Honeck P, Theuring M, Bolenz C, Ritter M. Wide-field autofluorescence-guided TUR-B for the detection of bladder cancer: a pilot study. World J Urol. 2017 Dec 6. doi: 10.1007/s00345-017-2147-9. [Epub ahead of print]

Kriegmair MC, Bergen T, Ritter M, Mandel P, Michel MS, Wittenberg T, Bolenz C. Digital Mapping of the Urinary Bladder: Potential for Standardized Cystoscopy Reports. Urology. 2017 Jun;104:235-241. doi: 10.1016/j.urology.2017.02.019. Epub 2017 Feb 16.

Martini T, Gilfrich C, Mayr R, Burger M, Pycha A, Aziz A, Gierth M, Stief CG, Müller SC, Wagenlehner F, Roigas J, Hakenberg OW, Roghmann F, Nuhn P, Wirth M, Novotny V, Hadaschik B, Grimm MO, Schramek P, Haferkamp A, Colleselli D, Kloss B, Herrmann E, Fisch M, May M, Bolenz C. The Use of Neoadjuvant Chemotherapy in Patients With Urothelial Carcinoma of the Bladder: Current Practice Among Clinicians. Clin Genitourin Cancer. 2017 Jun;15(3):356-362. doi: 10.1016/j.clgc.2016.09.003. Epub 2016 Sep 19. PMID: 27765613

Martini T, Wezel F, Löbig N, Mitterberger MJ, Colleselli D. [Systematic review on conservative treatment options in non-muscle-invasive bladder cancer patients refractory to Bacillus Calmette-Guérin instillation therapy]. Aktuelle Urol. 2017 Aug;48(4):314-328. doi: 10.1055/s-0043-108944. Epub 2017 Jun 13. German.  PMID: 28609792

Martinschek A, Stumm L, Ritter M, Heinrich E, Bolenz C, Trojan L. Prospective, Controlled Study of Invasiveness and Post-Aggression Metabolism in Patients Undergoing Robotic-Assisted Radical Prostatectomy. Urol Int. 2017;99(2):201-206. doi: 10.1159/000478027. Epub 2017 Jul 29.
May M, Protzel C, Vetterlein MW, Gierth M, Noldus J, Karl A, Grimm T, Wullich B, Grimm MO, Nuhn P, Bastian PJ, Roigas J, Hadaschik B, Gilfrich C, Burger M, Fisch M, Brookman-May S, Aziz A, Hakenberg OW; PROMETRICS 2011 Research Group. Is there evidence for a close connection between side of intravesical tumor location and ipsilateral lymphatic spread in lymph node-positive bladder cancer patients at radical cystectomy? Results of the PROMETRICS 2011 database. Int Urol Nephrol. 2017 Feb;49(2):247-254. doi: 10.1007/s11255-016-1469-7. Epub 2016 Nov 28.

Ralla B, Arnold H, König J, Cebulla A, Nestler T, Struck J, Borgmann H, Salem  J. Relaunch of the GeSRU website : Strategy, concept, and realization. Urologe A. 2017 Apr;56(4):512-514. doi: 10.1007/s00120-017-0367-7. German. PubMed PMID:28293704.

Reutter H, Hirsch K, Stein R, Rösch WH, Ebert AK. Sexual Function and Quality of Life in Adult Male Individuals with Exstrophy-Epispadias Complex - a Survey of the German CURE-Network. Traceviciute J, Zwink N, Jenetzky E, Urology. 2017 Nov 7. pii: S0090-4295(17)31160-3. doi: 10.1016/j.urology.2017.08.063. [Epub ahead of print]

Rinaldetti S, Wirtz RM, Worst TS, Eckstein M, Weiss CA, Breyer J, Otto W, Bolenz C, Hartmann A, Erben P. FOXM1 predicts overall and disease specific survival in muscle-invasive urothelial carcinoma and presents a differential expression between bladder cancer subtypes. Oncotarget. 2017 Jul 18;8(29):47595-47606. doi: 10.18632/oncotarget.17394.

Struck JP, Paffenholz P, Nachite S, Cebulla A, Ralla B, Salem J. GeSRU e. V. - a success story. Urologe A. 2017 Feb;56(2):245-246. doi:10.1007/s00120-016-0306-z. German. PubMed PMID: 28093612.

Vallo S, Rutz J, Kautsch M, Winkelmann R, Michaelis M, Wezel F, Bartsch G,
Haferkamp A, Rothweiler F, Blaheta RA, Cinatl Jr J Jr. Blocking integrin β1
decreases adhesion in chemoresistant urothelial cancer cell lines. Oncol Lett.
2017 Nov;14(5):5513-5518. doi: 10.3892/ol.2017.6883. Epub 2017 Sep 4. PubMed
PMID: 29113179; PubMed Central PMCID: PMC5661377.

Vallo S, Köpp R, Michaelis M, Rothweiler F, Bartsch G, Brandt MP, Gust KM, Wezel F, Blaheta RA, Haferkamp A, Cinatl J Jr. Resistance to nanoparticle albumin-bound paclitaxel is mediated by ABCB1 in urothelial cancer cells. Oncol Lett. 2017 Jun;13(6):4085-4092. doi: 10.3892/ol.2017.5986. Epub 2017 Apr 5. PubMed PMID: 28599410; PubMed Central PMCID: PMC5453046.

Vetterlein MW, Gild P, Kluth LA, Seisen T, Gierth M, Fritsche HM, Burger M, Protzel C, Hakenberg OW, von Landenberg N, Roghmann F, Noldus J, Nuhn P, Pycha A, Rink M, Chun FK, May M, Fisch M, Aziz A; PROMETRICS 2011 Study Group. Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre study. BJU Int. 2017 Sep 14. doi: 10.1111/bju.14012. [Epub ahead of print]

Vetterlein MW, Meyer CP, Leyh-Bannurah SR, Mayr R, Gierth M, Fritsche HM, Burger M, Keck B, Wullich B, Martini T, Bolenz C, Pycha A, Hanske J, Roghmann F, Noldus J, Bastian PJ, Gilfrich C, May M, Rink M, Chun FK, Dahlem R, Fisch M, Aziz A; Effect of Hospital and Surgeon Case Volume on Perioperative Quality of Care and Short-term Outcomes After Radical Cystectomy for Muscle-invasive Bladder Cancer: Results From a European Tertiary Care Center Cohort. PROMETRICS 2011 study group. Clin Genitourin Cancer. 2017 Oct;15(5):e809-e817. doi: 10.1016/j.clgc.2017.04.021. Epub 2017 Apr 26. PMID: 28550955

VON Hardenberg J, Schwartz M, Werner T, Fuxius S, Müller M, Frangenheim T, Bolenz C, Weiss C, Heinrich E. Prospective Evaluation of Neuromediator Dynamics in Castration-Resistant Prostate Cancer Patients During Docetaxel. Anticancer Res. 2017 Sep;37(9):5117-5124.
von Hardenberg J, Schwartz M, Werner T, Fuxius S, Strauss A, Worst TS, Nuhn P, Bolenz C, Heinrich E. Oncologic Response and Hospitalization Rate of Patients Receiving Cabazitaxel in the Fourth-Line and Beyond in Castration-Resistant Prostate Cancer: Analysis of a Retrospective Cohort and a Structured Literature Review. Urol Int. 2017;99(4):414-421. doi: 10.1159/000477943. Epub 2017 Jul 13.

K Walter, M Ventura Ferreira, V Usachov, S Alcala, C Günes, T Seufferlein, B Sainz Anding, A Kleger, F Beier, P Hermann. Telomeraseinhibition führt zur Elimination von tumor-initiierenden Zellen im humanen Pankreaskarzinom. Zeitschrift für Gastroenterologie

Weber R, Cebulla A, Nachite-Berges S, Paffenholz P, Salem J, Ralla B, Uhthoff  H, Schröder A, Struck JP. [Upgrade of the resident's job exchange platform]. Urologe A. 2017 Oct;56(10):1333-1334. doi: 10.1007/s00120-017-0502-5. German. PubMed PMID: 28900656.

Wundrack FM, Paffenholz P, Probst K, Sanatgar N, Cebulla A, Nestler T, Struck  J, Nachite-Berges S, Salem J, Ralla B. [GeSRU programs at regional urology meetings in Germany 2017]. Urologe A. 2017 Jun;56(6):804-805. doi: 10.1007/s00120-017-0411-7. German. PubMed PMID: 28508940.

Zhang R, Knapp M, Suzuki K, Kajioka D, Schmidt JM, Winkler J, Yilmaz Ö, Pleschka M, Cao J, Kockum CC, Barker G, Holmdahl G, Beaman G, Keene D, Woolf AS, Cervellione RM, Cheng W, Wilkins S, Gearhart JP, Sirchia F, Di Grazia M, Ebert AK, Rösch W, Ellinger J, Jenetzky E, Zwink N, Feitz WF, Marcelis C, Schumacher J, Martinón-Torres F, Hibberd ML, Khor CC, Heilmann-Heimbach S, Barth S, Boyadjiev SA, Brusco A, Ludwig M, Newman W, Nordenskjöld A, Yamada G, Odermatt B, Reutter H. ISL1 is a major susceptibility gene for classic bladder exstrophy and a regulator of urinary tract development. Sci Rep. 2017 Feb 8;7:42170. doi: 10.1038/srep42170.